Wolfgang Schmider

Morning administration of 0.4 U/kg/day insulin glargine 300 U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100 U/mL in type 1 diabetes

Timothy S. Bailey, Jeremy Pettus, Ronan Roussel et al. · Diabetes & Metabolism · 2017 · 94 citations · Full text

6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases

Stefan Welte, Karl‐Heinz Baringhaus, Wolfgang Schmider et al. · Analytical Biochemistry · 2004 · 77 citations

Protein Tyrosine Phosphatases, Protein Function, Protein Phosphorylation +1

Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes

Christoph Kapitza, Leszek Nosek, Wolfgang Schmider et al. · Diabetes Technology & Therapeutics · 2019 · 18 citations · Full text

Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytes

Gerhard Pütz, Wolfgang Schmider, Roland Nitschke et al. · Journal of Lipid Research · 2005 · 16 citations · Full text

Irreversible inhibition of hepatic fatty acid salt uptake by photoaffinity labeling with 11, 11-azistearate

Wolfgang Schmider, Alfred Fahr, Raphael Voges et al. · Journal of Lipid Research · 1996 · 15 citations · Full text